2002
DOI: 10.1136/gut.51.2.155
|View full text |Cite
|
Sign up to set email alerts
|

Defining the roles of perforin, Fas/FasL, and tumour necrosis factor   in T cell induced mucosal damage in the mouse intestine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

11
92
0

Year Published

2004
2004
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 93 publications
(103 citation statements)
references
References 41 publications
11
92
0
Order By: Relevance
“…In mice, acute T cell activation following i.p. injection of T cell-activating anti-CD3 mAb leads to severe small intestinal mucosal damage characterized by villus blunting and apoptosis of IEC (13). Therefore, i.p.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…In mice, acute T cell activation following i.p. injection of T cell-activating anti-CD3 mAb leads to severe small intestinal mucosal damage characterized by villus blunting and apoptosis of IEC (13). Therefore, i.p.…”
Section: Discussionmentioning
confidence: 99%
“…The model of anti-CD3 mAb i.p. injection was developed to study T cell driven inflammatory diseases such as IBD, celiac disease, or graft-versus-host disease (13). In mice, acute T cell activation following i.p.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Despite the reduced numbers of T H cells in the LP of Hic1 DT mice and the dysregulated production of IL-17A by HIC1-deficient T H 17 cells, we failed to observe any significant differences in intestinal architecture between naive Hic1 fl/fl or Hic1 DT mice (Figure 6a, left panels). After induction of intestinal inflammation with intraperitoneal injection of a monoclonal antibody against CD3, [30][31][32] Hic1 DT mice displayed less intestinal inflammation compared with control Hic1 fl/fl mice (Figures 6a and b). Although we observed fewer CD4 þ T cells in the intestine of treated Hic1 DT mice (Figure 6c), we did observe an increase in the number of CD4 þ T cells in the LP of treated Hic1 DT mice compared with naive Hic1 DT mice (Figures 2a and b), further demonstrating that intestinal migration is not completely impaired in the absence of HIC1.…”
Section: Hic1 Regulates T Cell-mediated Inflammation In the Intestinementioning
confidence: 99%
“…T cells have been found to possess various potent antitumor effects through releasing cytotoxic effector molecules such as perforin or growth-suppressive cytokines IFN-γ and TNF-α [18][19][20][21] . However, the frequency of tumor-specific T cells could is generally too low and insufficient to interfere with progressive tumor growth.…”
Section: Discussionmentioning
confidence: 99%